On the other hand, we found that in HP-positive patients, carriers of at least one GSTO1*A variant allele had significantly increased odds of developing gastric atrophy and precancerous gastric lesions (gastric atrophy and/or intestinal metaplasia) compared with carriers of the GSTO1*C reference allele. The gene discussed is GSTO1; the disease is chronic atrophic gastritis.